2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Pneumonia, Pneumococcal: new trials by email Literature Review of Pneumonia, Pneumococcal trials Research Report on Pneumonia, Pneumococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 COVAX+PPV23;COVAX+IIV4, COVAX only (1st and 2nd dose), PPV23 for the 1st dose and IIV4 for the 2nd dose - Influenza, Human, Pneumonia, Pneumococcal | Phase 4 | Unknown | China National Biotec Group Company Limited | 1404 | 2021-05-06 | 2021-10-15 |
| PCV10 Reactogenicity and Immunogenicity Study - Malindi PCV10 and DTaP, hepatitis A vaccine, DTaP, PCV10 - Pneumococcal Pneumonia | Phase 4 | Unknown | KEMRI-Wellcome Trust Collaborative Research Program | 600 | 2010-01-01 | 2018-02-23 |
Influenza, Human (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Lung Diseases (2) · Pneumococcal Infections (2) · Pneumonia (2) · Pneumonia, Bacterial (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Streptococcal Infections (2) · Orthomyxoviridae Infections (1) · RNA Virus Infections (1) · Virus Diseases (1)
10-valent pneumococcal conjugate vaccine (1) · Hepatitis A Vaccines (1) · PHiD-CV vaccine (1)
China National Biotec Group Company Limited (1) · KEMRI-Wellcome Trust Collaborative Research Program (1)
China (1) · Kenya (1)